100% Genuine
Cold-Chain Sourced
Lorbriqua 25mg Tablet
Prescription Required
Specialty Oncology

Lorbriqua 25mg Tablet

Lorlatinib (25mg)

Composition:Lorlatinib (25mg)
Manufacturer:Pfizer Ltd
Packaging:30.0 tablets in 1 box

Specialized Oncology Sourcing

Contact our pharmacy desk on WhatsApp or call for verified availability & exact price.

Free Express Cold-Chain Delivery

Temperature-controlled dispatch across India within 4 to 24 hours.

Licensed Network
2°C–8°C Storage
Rx Verification
Express Dispatch

About this medicine

Lorbriqua 25mg Tablet (Lorlatinib (25mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.

Lorbriqua 25mg Tablet is used to treat adults with unresectable (unremovable), advanced, or recurrent forms of non-small cell lung cancer (NSCLC). It works by inhibiting an enzyme called anaplastic lymphoma kinase (ALK) and is given to patients who have an alteration in this enzyme.Furthermore, This medicine is prescribed only to those patients who no longer respond to other ALK inhibitors, such as alectinib or ceritinib. Additionally, it is also effective in treating ALK-positive NSCLC that has spread to the brain.Take this medicine with or without food, but preferably at the same time each day. Depending on the condition and response to the treatment, the doctor may alter the dose or stop the treatment for a short time. Continue taking this medicine for as long as the doctor has prescribed, and do not stop suddenly.Some common side effects of This medicine include edema (swelling in arms, legs, hands, and feet), peripheral neuropathy (numbness and tingling feeling in joints, arms, and legs), and cognitive disorders (confusion, forgetfulness, and lack of concentration or attention). It may also cause breathlessness, fatigue, weight gain, joint pain, mood changes, and diarrhea. Consult the doctor if any of these side effects are worrisome or worsen. They may adjust the medicine dose and suggest ways to manage them.Let the doctor know if you have any medical conditions, such as kidney or heart disease, depression, seizures, problems with the heartbeat, or breathing problems. Also, let them know if you have high blood pressure, high levels of cholesterol, or diabetes before starting the treatment with this medicine. Pregnant or breastfeeding women should also consult their doctor before taking this medicine. Some other medications may affect the working of this tablet; therefore, tell the doctor about all the other medicines you may be taking before starting the treatment with this medicine.There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Generic Name

Lorlatinib (25mg)

Dosage Form

Tablet

Prescription Status

Doctor's Rx Required

Therapeutic Indications & Uses

Treatment of Non-small cell lung cancer

Potential Side Effects & Safety Guidance

Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.

Fatigue
Diarrhea
Edema (swelling)
High blood pressure
Cough
Joint pain
Peripheral neuropathy (tingling and numbness of feet and hand)
Weight gain
Breathlessness
Mood changes
Hypercholesterolemia (high cholesterol)
Increased triglyceride level in blood

Cold-Chain Temperature Protocol

Maintained at strict 2°C to 8°C throughout transit to preserve drug potency.

2°C - 8°C Guaranteed

Temperature Monitoring

Sourced from certified cold-storage warehouses.

Insulated Transit

Dispatched in gel-ice thermal insulated boxes.

Rx Verification

Prescription validated prior to cold dispatch.

Medical information standards

Educational product information for Lorbriqua 25mg Tablet. Not a substitute for advice from your oncologist or treating doctor.

Reviewed by
Vyloo Pharmacist TeamLicensed pharmacy model · Drug licence RLF21DL2025001406. See our medical review policy.
Content dates
Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
Business address
Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, India
GSTIN 07AAKCV0933E1ZF. More on our drug licence page.

Authoritative references

Have questions about your cancer prescription?

Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.

WhatsAppDidn't find a medicine?Whatsapp Us!